SOCMA recently submitted a formal letter to United States Trade Representative (USTR), Ambassador Katherine Tai, requesting a meeting on the 301 China Tariffs. The purpose of the meeting is not only to urge USTR to reopen the exclusion process for chemicals imported from China, but to educate and inform USTR on the concerns and impacts of the tariffs on the specialty chemicals industry.
As the specialty chemicals industry anticipates new policy and regulations coming under the Biden Administration, the Society of Chemical Manufacturers & Affiliates (SOCMA) is hosting its Policy Webinar Series throughout April to focus these key topics that are crucial to its membership and the value chain.
SOCMA Looks Forward to Partnering on Key Trade Issues with Newly Appointed U.S. Trade Representative Katherine Tai
The Society of Chemical Manufacturers & Affiliates (SOCMA) congratulates Katherine Tai on her recent landmark appointment as the United States Trade Representative under the Biden Administration.
The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.
April 8, 2019 Office of the Secretary U.S. International Trade Commission 500 E Street SW Washington, D.C. 20436 Investigation No.... View Article
ARLINGTON, VA – The Society of Chemical Manufacturers & Affiliates (SOCMA) today testified before the U.S. International Trade Commission (USITC) to emphasize the benefits of Miscellaneous Tariff Bills (MTB) and advocate for permanent duty suspensions and reductions.